AstraZeneca Acquires Modella AI to Accelerate Oncology Research with In-House Artificial Intelligence
AstraZeneca is deepening its commitment to AI-driven drug development by acquiring Boston-based Modella AI, integrating its models, data, and team to enhance oncology research and clinical trial efficiency.
